Press Releases

The global stem cell therapy market is expected to witness a CAGR of 12.6% during the forecast period 2025-2030 and is also anticipated to reach USD 265.5 billion by 2030. Growing awareness related to the therapeutic potency of stem cells, development of infrastructure related to stem cell banking and processing, development of advanced genome-based cell analysis techniques, and increasing private-public investment for the development of stem cell therapies are driving the growth of the stem cell therapy market. 

Supportive regulations to drive the growth of the stem cell therapy market

Supporting regulations across developing countries, increasing prevalence of chronic diseases, technological advancement in healthcare, and cellular therapies are the major advancements in transforming healthcare and the identification of new stem cell lines is also fueling the growth of the stem cell therapy market.

Diseases such as osteoarthritis, multiple sclerosis, heart failure, hearing loss, and cerebral palsy are some of the diseases that could be treated using stem cell therapies. For instance, according to the WHO by 2050, it is estimated 900 million people will have disabling hearing loss. Moreover, 60 percent of childhood hearing loss is due to preventable causes.

Global Stem Cell Therapy Market Segmentation and Key Players

Browse Market Insight and In-depth TOC on "Global Stem Cell Therapy Market – Analysis and Forecast (2025-2030)"

Allogenic stem cell therapy market to hold a larger share of the market

There are two types of stem cell therapy, allogeneic and autologous. Of both, the allogenic segment accounts for the larger share and is also predicted to grow at a faster rate in the coming years in the market due to its extensive therapeutic applications, increasing commercialization of allogeneic products, easy production scale-up process, and the growing number of clinical trials related to allogeneic therapies. 

The stem cell therapy market has been segmented by therapeutic application into gastrointestinal diseases, musculoskeletal disorders, surgeries, cardiovascular diseases, and wounds and injuries. The musculoskeletal disorders category contributed the largest revenue in the market due to the increasing prevalence of musculoskeletal disorders and bone & joint diseases, increasing the availability of stem cell-based products for the treatment of musculoskeletal disorders, and growing patient preference for effective & early treatment strategies.

The global stem cell therapy market has also been segmented by cell source into an adipose tissue-derived mesenchymal stem cell, cord blood cells, and bone marrow-derived mesenchymal stem cells. Of all the categories, bone marrow-derived mesenchymal stem cells are increasingly being used for therapeutic applications.

North America offers huge opportunities for stem cell therapy industry players

The North American stem cell therapy market will remain the largest during the forecast period. The region is further predicted to observe the fastest growth during the forecast period in the global market owing to technological upgradation and large capital invested in research and development activities. Moreover, the increasing number of clinical trials to evaluate the therapeutic potential of products, the increasing prevalence of chronic diseases, the growing patient base for target diseases, growing public awareness related to the therapeutic potency of therapy, and increasing public-private funding & research grants for developing safe and effective stem cell therapy products are also supporting the growth of the North American stem cell therapy market. 

Investing in research and development is the key strategy adopted by the market players

Major players in the industry are investing in the development of innovative and new products, which is strengthening their position in the stem cell therapy market. In February 2018, MEDIPOST announced that the FDA had approved its stem cell-based Alzheimer’s disease drug, NEUROSTEM for clinical trials. Similarly, in March 2017, Osiris Therapeutics launched Prestige Lyotechnology, a method for the storage of living cells and tissues.

Some of the key players operating in the stem cell therapy industry are Osiris Therapeutics, Inc., RTI Surgical, Inc., MEDIPOST Co., Ltd., Nuvasive, Inc., Pharmicell Co., Ltd., Holostem Terapie Avanzate Srl, JCR Pharmaceuticals Co., Ltd., Anterogen Co., Ltd., and Allosource.

Global Stem Cell Therapy Market Coverage

Type Insight and Forecast 2025-2030

• Allogeneic
• Autologous

Cell Source Insight and Forecast 2025-2030

• Adipose Tissue-Derived Mesenchymal Stem Cell
• Cord Blood Cells
• Bone Marrow-Derived Mesenchymal Stem Cells

Therapeutic Application Insight and Forecast 2025-2030

• Gastrointestinal Diseases
• Musculoskeletal Disorders
• Surgeries
• Cardiovascular Diseases
• Wound & Injuries

Geographic Segmentation

Stem Cell Therapy Market by Region

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • U.K.
  • France
  • Rest of Europe
• Asia-Pacific
  • Japan
  • China
  • India
  • Rest of Asia-Pacific
• ROW
  • Brazil
  • Other Countries

Key Takeaway from the Report:

• The R&D investment to increase multi-fold over the next few years.
• More and more FDA-approved therapies to entering the market.
• Improvement in the regulatory scenarios to create a positive environment for the players.
• Anticipated acquisitions and collaboration for technology transfer.
• North America will remain the center of all the developments across the globe.

The Report Offers:

• Historical market estimate for the years 2018–2023 and forecast for the years 2025–2030
• Insight on current market trends, market dynamics, key opportunities and major challenges in the industry
• Market insights by in-depth segmentation with industry dynamics.
• Competitive analysis and benchmarking of the industry leaders and their product offerings
• Profiles of leading players and innovators, their financial overview, and product portfolio
• Analysis of key industry trends and recent developments
• Value chain analysis and distribution channel analysis with opportunity assessment

Benefits of Report Purchase from VynZ:

• Detailed Research: We provide accurate data and in-depth analysis with all-inclusive coverage.
• Robust Research Methodology: Robust research methodology and data triangulation to ensure a high-quality report.
• Analyst Support: 24*7 analyst support – Pre and post-purchase of the report as well as during the project tenure.
• Sales Support: 24*7 sales support – Hassle-free delivery of the report and quick response and support by the sales team.
• Free Customization: 20% post-purchase free customization to meet your requirements.
• Customer Satisfaction: We claim full customer satisfaction as our core values lie in building long-term relationships.
• Security: High level of data security and confidentiality of your information.